| 000 | 01690 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250513164218.0 | ||
| 264 | 0 | _c19991005 | |
| 008 | 199910s 0 0 eng d | ||
| 022 | _a1076-1551 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBatliwalla, F M | |
| 245 | 0 | 0 |
_aA 15-year follow-up of AJCC stage III malignant melanoma patients treated postsurgically with Newcastle disease virus (NDV) oncolysate and determination of alterations in the CD8 T cell repertoire. _h[electronic resource] |
| 260 |
_bMolecular medicine (Cambridge, Mass.) _cDec 1998 |
||
| 300 |
_a783-94 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntigens, Neoplasm _xtherapeutic use |
| 650 | 0 | 4 |
_aCD3 Complex _ximmunology |
| 650 | 0 | 4 |
_aCD57 Antigens _ximmunology |
| 650 | 0 | 4 |
_aCD8-Positive T-Lymphocytes _ximmunology |
| 650 | 0 | 4 |
_aCancer Vaccines _xtherapeutic use |
| 650 | 0 | 4 |
_aClone Cells _ximmunology |
| 650 | 0 | 4 | _aCombined Modality Therapy |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFlow Cytometry |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunotherapy |
| 650 | 0 | 4 |
_aLymph Nodes _xsurgery |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMelanoma _ximmunology |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNewcastle disease virus _ximmunology |
| 650 | 0 | 4 |
_aSkin Neoplasms _ximmunology |
| 700 | 1 | _aBateman, B A | |
| 700 | 1 | _aSerrano, D | |
| 700 | 1 | _aMurray, D | |
| 700 | 1 | _aMacphail, S | |
| 700 | 1 | _aMaino, V C | |
| 700 | 1 | _aAnsel, J C | |
| 700 | 1 | _aGregersen, P K | |
| 700 | 1 | _aArmstrong, C A | |
| 773 | 0 |
_tMolecular medicine (Cambridge, Mass.) _gvol. 4 _gno. 12 _gp. 783-94 |
|
| 999 |
_c9952259 _d9952259 |
||